查看購物車
  • Simplified Chinese
  • English
  • Japanese
腸內和腸外醫療營養市場預測至2028年 - COVID-19的影響以及按適應症、營養類型、形式、產品類型、給藥途徑、年齡層和配銷通路的全球分析
市場調查報告書
商品編碼
1296779

腸內和腸外醫療營養市場預測至2028年 - COVID-19的影響以及按適應症、營養類型、形式、產品類型、給藥途徑、年齡層和配銷通路的全球分析

Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Global Analysis by Indication, Nutrition Type, Form, Product Type, Route of Administration, Age Group, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 720 Pages | 訂單完成後即時交付

價格

腸內和腸外醫療營養市場規模預計將從2022年的173.4億美元成長到2028年的254.7億美元；估計從2023年到2028年的複合成長率為6.8%。

腸內和腸外醫療營養市場的成長歸因於胃腸道疾病患病率的上升以及營養不良和早產病例的增加。

對幫助消費者主動管理其健康的產品需求激增，特別是那些致力於能階、免疫力和疾病治療方面的特定需求的產品。營養需求根據疾病的類型而有所不同。腸內和腸外產品的功能和特定配方不會干擾提供給病人的現有治療，並有助於按照要求提供更精確和更多的治療。腸內和腸外營養的宏觀和微觀營養素配方及其應用根據各種疾病（如癌症和胃腸道疾病）而有所不同。此外，製藥公司提供的腸內和腸外營養的成分是個性化的（針對病人）。例如，Impact（由雀巢公司提供）是一種經過臨床驗證的營養解決方案，用於管理接受重大選擇性手術的患者，以減少術後併發症和住院時間，改善臨床結果。公司努力為獨特需求提供此類配方，將推動腸道和腸外醫療營養市場的成長。

此外，各種組織努力傳播對使用特定營養配方的認知。例如，美國腸外和腸內營養協會（稱為ASPEN）是總部設在美國的醫療專業組織，僱用了營養師、藥劑師、醫生和助理、護士、執業護士、科學家、學生以及其他來自各個營養領域的健康專家，為病人提供臨床營養並對其進行教育。這些因素將支援腸道和腸外醫療營養市場在未來的成長。

此外，轉向植物性食物的人數激增，引發了全球對植物性營養產品的需求。人們更有可能對使用較多的人工/合成成分表現出不耐受，這可能導致不良反應。因此，成分越少，最終產品就越好。 2020年Innova消費者調查顯示，健康、飲食多樣性、永續性和口味是人們考慮植物性替代品的首要原因。據雅培公司指出，消費者和依靠管餵的病人也不例外，都是這種趨勢的受益者。美國醫學協會呼籲醫療機構提出以植物為基礎的膳食選擇，以改善病人的健康。包括加利福尼亞州、紐約州和哥倫比亞特區在內的各州已經要求醫院向所有病人提供健康的植物性膳食。腸內和腸外醫療營養市場的公司預計，對健康食品的日益關注將轉化為對更健康營養產品的偏好。 2021年9月，雅培公司為兒童和成人推出了植物性蛋白質和有機食品原料的產品組合。同樣，基於橄欖油的腸外營養產品也越來越受歡迎。

因此，功能性、以病人為中心的配方和基於植物的營養產品是腸內和腸外醫療營養市場的主要新興趨勢。

基於年齡層的洞察力

基於年齡層，腸內和腸外醫療營養市場分為60歲以上、18-60歲、3-18歲和3歲以下。 2022年，60歲以上部分在腸內和腸外醫療營養市場中佔最大佔有率。然而，在預測期內，18-60歲的部分預計將註冊最高的年複合成長率。體重下降和營養不良在60歲以上的人中很常見。隨著年齡的成長，老年人口的免疫力下降，他們變得更容易受到可能惡化他們健康的疾病。由於這個原因，醫生開出了外部營養來維持免疫力和體重。根據發表在PubMed Central的幾項研究，慢性病和殘疾的發病率在老年人中明顯更高，產生了對家庭治療的需求。另外，根據人口資料局（2019年）的估計，美國的老年人口預計將從2018年的5200萬成長到2060年的9500萬。由於老年群體的殘疾，對家庭護理的需求不斷增加，家庭治療的需求也隨之增加。因此，老年人口基數的增加預計將促進腸道和腸外醫療營養市場的細分市場的成長。

英國腸外和腸內營養協會、美國疾病控制和預防中心（CDC）以及全球疾病負擔研究是編寫腸內和腸外醫療營養市場報告時參考的主要和次要資料來源。

目錄

第一章：簡介

  • 本研究的範圍
  • Insight Partners的研究報告指南
  • 市場細分
    • 全球腸內和腸外醫療營養市場- 按適應症分類
    • 全球腸內和腸外醫療營養市場- 按營養類型分類
    • 全球腸內和腸外醫療營養市場- 按形式分類
    • 全球腸內和腸外醫療營養市場- 按產品類型分類
    • 全球腸內和腸外醫療營養市場- 按給藥途徑分類
    • 全球腸內和腸外醫療營養市場- 按年齡層分類
    • 全球腸內和腸外醫療營養市場- 按銷售管道分類
    • 全球腸內和腸外醫療營養市場- 按地域分類

第二章：主要結論

第三章：研究方法

  • 涵蓋範圍
  • 二級研究
  • 初級研究

第四章：腸內和腸外醫療營養市場- 市場格局

  • 概述
  • PEST分析
    • 北美洲PEST分析
    • 歐洲PEST分析
    • 亞太地區PEST分析
    • 中東和非洲PEST分析
    • 南美和中美洲PEST分析
  • 專家意見
  • 能量含量分析
    • 低於1.5千卡/毫升
    • 相當於1.5千卡/毫升
    • 低於2千卡/毫升
    • 等於或高於2kcal/ml：

第五章：腸內和腸外醫療營養品市場-主要市場動態

  • 市場驅動力
    • 胃腸道疾病發病率的上升
    • 營養不良和早產的病例不斷增加
  • 市場限制因素
    • 與腸內和腸外餵養系統相關的機械、胃腸道和代謝併發症，以及與導管放置相關的限制。
  • 市場機會
    • 公司的戰略計劃不斷增加
  • 未來趨勢
    • 特定配方和植物性營養產品
  • 影響分析

第六章：腸內和腸外醫療營養市場- 全球分析

  • 全球腸內和腸外醫療營養品市場收入預測和分析
    • 全球腸內和腸外醫療營養品市場，按地域分類- 預測和分析
  • 公司分析
    • 主要企業的市場定位
  • 腸內和腸外醫療營養品市場的市場佔有率分析

第7章：全球腸內和腸外醫療營養市場- 收入和預測到2028年- 按適應症分類

  • 概述
  • 腸內和腸外醫療營養市場收入佔有率，按適應症分類2022年和2028年（%）。
  • 老年人
  • 胃腸道疾病
  • 糖尿病
  • 癌症
  • 呼吸系統疾病
  • 阿爾茨海默氏病
  • 失智症
  • 腎臟疾病
  • 肝衰竭
  • COVID-19後
  • 其他適應症

第八章：全球腸內和腸外醫療營養市場- 收入和預測到2028年- 按營養類型分類

  • 概述
  • 腸內和腸外醫療營養市場收入佔有率，按營養類型分類2022年和2028年（%）。
  • 補充型
  • 單一來源

第九章：全球腸內和腸外醫療營養品市場- 收入和預測到2028年- 按形式分類

  • 概述
  • 腸內和腸外醫療營養市場收入佔有率，按形式分類2022 & 2028 (%)
  • 液體
  • 粉末
  • 半固體

第十章：全球腸內和腸外醫療營養品市場- 收入和預測到2028年- 按產品類型分類

  • 概述
  • 2022年和2028年按產品類型分類的腸內和腸外醫療營養品市場收入佔有率（%）。
  • 一般
  • 特異性疾病

第11章：全球腸內和腸外醫療營養市場- 收入和預測到2028年- 按給藥途徑分類

  • 概況
  • 2022年和2028年按給藥途徑分類的腸內和腸外醫療營養市場收入佔有率(%)
  • 口服
  • 管餵
  • 腸外

第12章：全球腸內和腸外醫療營養市場- 收入和預測到2028年- 按年齡層分類

  • 概覽
  • 2022年和2028年按年齡層分類的腸內和腸外醫療營養市場收入佔有率（%）
  • 60歲以上
  • 18-60歲
  • 3-18歲
  • 3歲以下

第13章：全球腸內和腸外醫療營養品市場- 收入和預測到2028年- 按配銷通路分類

  • 概覽
  • 2022年和2028年按配銷通路分類的腸內和腸外醫療營養品市場收入佔有率（%）
  • 醫院藥房
  • 零售店
  • 電子商務
  • 其他管道

第十四章：腸內和腸外醫療營養品市場- 收入和預測到2028年- 地域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
Product Code: TIPRE00029916

The enteral and parenteral medical nutrition market size is expected to grow from US$ 17.34 billion in 2022 to US$ 25.47 billion by 2028; it is estimated to record a CAGR of 6.8% from 2023 to 2028.

The enteral and parenteral medical nutrition market growth is attributed to the rise in the prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Efforts of companies for offering such formulations for unique need will propel the growth of the enteral and parenteral medical nutrition market.

Additionally, various organizations are making efforts to spread awareness of the use of specific nutritional formulations. For instance, the American Society for Parenteral and Enteral Nutrition (called ASPEN) is a US-based medical professional organization that employs dietitians, pharmacists, physicians and assistants, nurses, nurse practitioners, scientists, students, and other health professionals from every field of nutrition to provide clinical nutrition to patients and educate them. Such factors will support the enteral and parenteral medical nutrition market growth in the future.

Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. The American Medical Association is calling on healthcare facilities to propose plant-based meal options to improve patients' health. States including California, New York, and the District of Columbia have asked hospitals to make healthy, plant-based meals available to all patients. Companies in the enteral and parenteral medical nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults. Similarly, olive oil-based parenteral nutrition products are also gaining popularity.

Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral and parenteral medical nutrition market.

Age Group -Based Insights

Based on age group, the enteral and parenteral medical nutrition market is categorized into above 60 years, 18-60 years, 3-18 years, and below 3 years. In 2022, the above 60 years segment accounted for the largest share in enteral and parenteral medical nutrition market. However, the 18-60 years segment is anticipated to register the highest CAGR during the forecast period. Weight loss and malnutrition are common in people aged above 60 years. With increasing age, the immunity of the older population decreases, and they become more prone to diseases that may deteriorate their health. Due to this, doctors prescribe external nutrition to maintain immunity and weight. According to several studies published in PubMed Central, the prevalence of chronic diseases and disabilities is significantly higher among geriatric people, generating the need for home-based treatments. Also, as per the Population Reference Bureau (2019), it is estimated that the senior population of the US is expected to grow from 52 million in 2018 to 95 million by 2060. The need for home therapy has increased due to the growing demand for home care owing to disability among old age groups. Thus, the increasing geriatric population base is expected to promote the growth of segment in the enteral and parenteral medical nutrition market.

The British Association for Parenteral and Enteral Nutrition, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the enteral and parenteral medical nutrition market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the enteral and parenteral medical nutrition market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global enteral and parenteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Enteral and Parenteral Medical Nutrition Market - By Indication
    • 1.3.2 Global Enteral and Parenteral Medical Nutrition Market - By Nutrition Type
    • 1.3.3 Global Enteral and Parenteral Medical Nutrition Market - By Form
    • 1.3.4 Global Enteral and Parenteral Medical Nutrition Market - By Product Type
    • 1.3.5 Global Enteral and Parenteral Medical Nutrition Market - By Route of Administration
    • 1.3.6 Global Enteral and Parenteral Medical Nutrition Market - By Age Group
    • 1.3.7 Global Enteral and Parenteral Medical Nutrition Market - By Distribution Channel
    • 1.3.8 Global Enteral and Parenteral Medical Nutrition Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Enteral and Parenteral Medical Nutrition Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South And Central America PEST Analysis
  • 4.3 Experts Opinion
  • 4.4 Energy Content Analysis
    • 4.4.1 Lower than 1.5 kcal/ml
    • 4.4.2 Equals to 1.5 kcal/ml
    • 4.4.3 Lower than 2kcal/ml:
    • 4.4.4 Equal to or Higher than 2kcal/ml:

5. Enteral and Parenteral Medical Nutrition Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Gastrointestinal Diseases
    • 5.1.2 Increasing Cases of Malnutrition and Premature Births
  • 5.2 Market Restraints
    • 5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Enteral and Parenteral Feeding Systems, and Limitations Related to Catheter Placement
  • 5.3 Market Opportunities
    • 5.3.1 Growing Strategic Initiatives by Companies
  • 5.4 Future Trends
    • 5.4.1 Specific Formulations and Plant-Based Nutrition Products
  • 5.5 Impact Analysis

6. Enteral and Parenteral Medical Nutrition Market - Global Analysis

  • 6.1 Global Enteral and Parenteral Medical Nutrition Market Revenue Forecast and Analysis
    • 6.1.1 Global Enteral and Parenteral Medical Nutrition Market, By Geography - Forecast and Analysis
  • 6.2 Company Analysis
    • 6.2.1 Market Positioning of Key Players
  • 6.3 Market Share Analysis of Enteral and Parenteral Medical Nutrition Market

7. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Indication

  • 7.1 Overview
  • 7.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
    • 7.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
  • 7.3 Elderly
    • 7.3.1 Overview
    • 7.3.2 Elderly: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
  • 7.4 Gastrointestinal Disorders
    • 7.4.1 Overview
    • 7.4.2 Gastrointestinal Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
    • 7.4.3 Inflammatory Bowel Disease
      • 7.4.3.1 Overview
      • 7.4.3.2 IBD: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.3.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
    • 7.4.4 Irritable Bowel Syndrome
      • 7.4.4.1 Overview
      • 7.4.4.2 IBS: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.4.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
    • 7.4.6 Others
      • 7.4.6.1 Overview
      • 7.4.6.2 Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.6.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
  • 7.5 Diabetes
    • 7.5.1 Overview
    • 7.5.2 Diabetes: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.1.1 Global: Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
  • 7.6 Cancer
    • 7.6.1 Overview
    • 7.6.2 Cancer: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
  • 7.7 Respiratory Disorders
    • 7.7.1 Overview
    • 7.7.2 Respiratory Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.7.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form, 2020-2028 (US$ Million)
  • 7.8 Alzheimer's Disease
    • 7.8.1 Overview
    • 7.8.2 Alzheimer's Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
  • 7.9 Dementia
    • 7.9.1 Overview
    • 7.9.2 Dementia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.9.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
  • 7.10 Renal Disease
    • 7.10.1 Overview
    • 7.10.2 Renal Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.10.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
  • 7.11 Liver Failure
    • 7.11.1 Overview
    • 7.11.2 Liver Failure: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.11.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
  • 7.12 Post COVID-19
    • 7.12.1 Overview
    • 7.12.2 Post COVID-19: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.12.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
  • 7.13 Other Indications
    • 7.13.1 Overview
    • 7.13.2 Other Indications: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.13.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)

8. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Nutrition Type

  • 8.1 Overview
  • 8.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
    • 8.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
  • 8.3 Supplemental
    • 8.3.1 Overview
    • 8.3.2 Supplemental: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Sole-Source
    • 8.4.1 Overview
    • 8.4.2 Sole-Source: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Form

  • 9.1 Overview
  • 9.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
    • 9.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
  • 9.3 Liquid
    • 9.3.1 Overview
    • 9.3.2 Liquid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Powder
    • 9.4.1 Overview
    • 9.4.2 Powder: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Semi-Solid
    • 9.5.1 Overview
    • 9.5.2 Semi-Solid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

10. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Product Type

  • 10.1 Overview
  • 10.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
    • 10.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
  • 10.3 General
    • 10.3.1 Overview
    • 10.3.2 General: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Disease-Specific
    • 10.4.1 Overview
    • 10.4.2 Disease-Specific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

11. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Route of Administration

  • 11.1 Overview
  • 11.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
    • 11.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
  • 11.3 Oral
    • 11.3.1 Overview
    • 11.3.2 Oral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Tube Feed
    • 11.4.1 Overview
    • 11.4.2 Tube Feed: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Parenteral
    • 11.5.1 Overview
    • 11.5.2 Parenteral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

12. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Age Group

  • 12.1 Overview
  • 12.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
    • 12.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
  • 12.3 Above 60 Years
    • 12.3.1 Overview
    • 12.3.2 Above 60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.4 18-60 Years
    • 12.4.1 Overview
    • 12.4.2 18-60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.5 3-18 Years
    • 12.5.1 Overview
    • 12.5.2 3-18 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.6 Below 3 Years
    • 12.6.1 Overview
    • 12.6.2 Below 3 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

13. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Distribution Channel

  • 13.1 Overview
  • 13.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
    • 13.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
  • 13.3 Hospital Pharmacies
    • 13.3.1 Overview
    • 13.3.2 Hospital Pharmacies: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.4 Retail Stores
    • 13.4.1 Overview
    • 13.4.2 Retail Stores: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.5 E-Commerce
    • 13.5.1 Overview
    • 13.5.2 E-Commerce: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.6 Others
    • 13.6.1 Overview
    • 13.6.2 Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

14. Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 14.1 North America: Enteral and Parenteral Medical Nutrition Market
    • 14.1.9.1 US: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.1.9.2 Canada: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 14.2 Europe: Enteral and Parenteral Medical Nutrition Market
    • 14.2.1 Overview
    • 14.2.10.1 Germany: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.2 UK: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.3 France: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.4 Italy: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.5 Spain: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.6 Netherlands: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.7 Switzerland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.8 Poland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.9 Sweden: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.10 Belgium: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.11 Rest of Europe: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
  • 14.3 Asia Pacific: Enteral and Parenteral Medical Nutrition Market
    • 14.3.1 Overview
    • 14.3.9.1 China: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.1.1 Overview
    • 14.3.9.2 Japan: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.3 India: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.4 Australia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.5 South Korea: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.6 Indonesia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.7 Thailand: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.8 Vietnam: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.9 Rest of Asia Pacific: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
  • 14.4 Middle East & Africa Enteral and Parenteral Medical Nutrition Market
    • 14.4.1 Overview
    • 14.4.9.1 Saudi Arabia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.2 South Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.3 UAE: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.4 Iran: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.5 Israel: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.6 Egypt: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.7 Rest of Middle East & Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
  • 14.5 South & Central America Enteral and Parenteral Medical Nutrition Market
    • 14.5.1 Overview
    • 14.5.10.1 Mexico: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.2 Brazil: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.3 Argentina: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.4 Chile: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.5 Peru: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.6 Colombia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.7 Rest of South & Central America: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)

    15. Impact Of COVID-19 Pandemic on Enteral and Parenteral Medical Nutrition Market

    • 15.1 North America: Impact Assessment of COVID-19 Pandemic
    • 15.2 Europe: Impact Assessment of COVID-19 Pandemic
    • 15.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
    • 15.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
    • 15.5 South & Central America: Impact Assessment of COVID-19 Pandemic

    16. Enteral and Parenteral Medical Nutrition Market – Industry Landscape

    • 16.1 Overview
    • 16.2 Growth Strategies in the Enteral and Parenteral Medical Nutrition Market
    • 16.3 Inorganic Growth Strategies
    • 16.3.1 Overview
    • 16.4 Organic Growth Strategies
    • 16.4.1 Overview

    17. Company Profiles

    • 17.1 Abbott Laboratories
      • 17.1.1 Key Facts
      • 17.1.2 Business Description
      • 17.1.3 Products and Services
      • 17.1.4 Financial Overview
      • 17.1.5 SWOT Analysis
      • 17.1.6 Key Developments
    • 17.2 Nestle SA
      • 17.2.1 Key Facts
      • 17.2.2 Business Description
      • 17.2.3 Products and Services
      • 17.2.4 Financial Overview
      • 17.2.5 SWOT Analysis
      • 17.2.6 Key Developments
    • 17.3 Nutricia International BV
      • 17.3.1 Key Facts
      • 17.3.2 Business Description
      • 17.3.3 Products and Services
      • 17.3.4 Financial Overview
      • 17.3.5 SWOT Analysis
      • 17.3.6 Key Developments
    • 17.4 Medtrition Inc
      • 17.4.1 Key Facts
      • 17.4.2 Business Description
      • 17.4.3 Products and Services
      • 17.4.4 Financial Overview
      • 17.4.5 SWOT Analysis
      • 17.4.6 Key Developments
    • 17.5 Fresenius Kabi AG
      • 17.5.1 Key Facts
      • 17.5.2 Business Description
      • 17.5.3 Products and Services
      • 17.5.4 Financial Overview
      • 17.5.5 SWOT Analysis
      • 17.5.6 Key Developments
    • 17.6 B. Braun SE
      • 17.6.1 Key Facts
      • 17.6.2 Business Description
      • 17.6.3 Products and Services
      • 17.6.4 Financial Overview
      • 17.6.5 SWOT Analysis
      • 17.6.6 Key Developments
    • 17.7 Smartfish AS
      • 17.7.1 Key Facts
      • 17.7.2 Business Description
      • 17.7.3 Products and Services
      • 17.7.4 Financial Overview
      • 17.7.5 SWOT Analysis
      • 17.7.6 Key Developments
    • 17.8 Nutrisens SAS
      • 17.8.1 Key Facts
      • 17.8.2 Business Description
      • 17.8.3 Products and Services
      • 17.8.4 Financial Overview
      • 17.8.5 SWOT Analysis
      • 17.8.6 Key Developments
    • 17.9 AYMES International Ltd
      • 17.9.1 Key Facts
      • 17.9.2 Business Description
      • 17.9.3 Products and Services
      • 17.9.4 Financial Overview
      • 17.9.5 SWOT Analysis
      • 17.9.6 Key Developments
    • 17.10 Medifood International SA
      • 17.10.1 Key Facts
      • 17.10.2 Business Description
      • 17.10.3 Products and Services
      • 17.10.4 Financial Overview
      • 17.10.5 SWOT Analysis
      • 17.10.6 Key Developments
    • 17.11 Easy Line Ltd
      • 17.11.1 Key Facts
      • 17.11.2 Business Description
      • 17.11.3 Products and Services
      • 17.11.4 Financial Overview
      • 17.11.5 SWOT Analysis
      • 17.11.6 Key Developments
    • 17.12 Charing Cross Scientific AS
      • 17.12.1 Key Facts
      • 17.12.2 Business Description
      • 17.12.3 Products and Services
      • 17.12.4 Financial Overview
      • 17.12.5 SWOT Analysis
      • 17.12.6 Key Developments
    • 17.13 Baxter International Inc
      • 17.13.1 Key Facts
      • 17.13.2 Business Description
      • 17.13.3 Products and Services
      • 17.13.4 Financial Overview
      • 17.13.5 SWOT Analysis
      • 17.13.6 Key Developments
    • 17.14 Medica Nutrition Inc
      • 17.14.1 Key Facts
      • 17.14.2 Business Description
      • 17.14.3 Products and Services
      • 17.14.4 Financial Overview
      • 17.14.5 SWOT Analysis
      • 17.14.6 Key Developments

    18. Appendix

    • 18.1 About The Insight Partners
    • 18.2 Glossary of Terms

List Of Tables

List Of Figures

  • Figure 1. Enteral and Parenteral Medical Nutrition Market Segmentation
  • Figure 2. Enteral and Parenteral Medical Nutrition Market, By Region
  • Figure 3. Global Enteral and Parenteral Medical Nutrition Market Overview
  • Figure 4. Elderly Segment Held Largest Share of Indication Segment in Enteral and Parenteral Medical Nutrition Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Enteral and Parenteral Medical Nutrition Market, by Geography (US$ Million)
  • Figure 7. Global Enteral and Parenteral Medical Nutrition Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Enteral and Parenteral Medical Nutrition Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South And Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Impact Analysis
  • Figure 16. Global Enteral and Parenteral Medical Nutrition Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Enteral and Parenteral Medical Nutrition Market- By Geography Forecast and Analysis - 2022 & 2028
  • Figure 18. Market Positioning of Key Players in Enteral and Parenteral Medical Nutrition Market
  • Figure 19. Market Share Analysis of Key Players in Enteral and Parenteral Medical Nutrition Market (2022)
  • Figure 20. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
  • Figure 21. Elderly: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Gastrointestinal Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. IBD: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. IBS: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Diabetes: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Cancer: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Respiratory Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Alzheimer's Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Dementia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Renal Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Liver Failure: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Post COVID-19: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Other Indications: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
  • Figure 36. Supplemental: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Sole Source: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
  • Figure 39. Liquid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Powder: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Semi-Solid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
  • Figure 43. General: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Disease Specific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
  • Figure 46. Oral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Tube Feed: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Parenteral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
  • Figure 50. Above 60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. 18-60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. 3-18 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Below 3 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
  • Figure 55. Hospital Pharmacies: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Retail Stores: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. E-Commerce: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. North America: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 60. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. North America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 62. US: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Canada: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Europe: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 65. Europe Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Europe: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 67. Germany: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. UK: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. France: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Italy: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Spain: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 72. Netherlands: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 73. Switzerland: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 74. Poland: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 75. Sweden: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 76. Belgium: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 77. Rest of Europe: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 78. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 79. Asia Pacific Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 80. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 81. China: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 82. Japan: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 83. India: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 84. Australia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 85. South Korea: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 86. Indonesia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 87. Thailand: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 88. Vietnam: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 89. Rest of Asia Pacific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 90. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 91. Middle East & Africa Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 92. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 93. Saudi Arabia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 94. South Africa: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 95. UAE: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 96. Iran: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 97. Israel: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 98. Egypt: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 99. Rest of Middle East & Africa: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 100. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 101. South & Central America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 102. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 103. Mexico: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 104. Brazil: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 105. Argentina: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 106. Chile: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 107. Peru: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 108. Colombia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 109. Rest of South & Central America: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 110. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 111. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 112. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 113. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 114. Impact of COVID-19 Pandemic on South & Central American Country Markets
  • Figure 115. Growth Strategies in the Enteral and Parenteral Medical Nutrition Market